Medicare Enrolled
Dr. Ron Sklash, M.D.
Student in an Organized Health Care Education/Training Program · Long Beach, CA
Practice pattern: Remote & Cardiac
— Practice combining remote and cardiac services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sklash from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sklash?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sklash
Dr. Ron Sklash is a student in an organized health care education/training program specialist in Long Beach, CA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Sklash performed 6,530 Medicare services across 2,551 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sklash received a total of $18,265 from 58 pharmaceutical and/or device companies across 861 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in student in an organized health care education/training program. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sklash is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 3% volume in CA
$18,265 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,530
Medicare services
Top 3% in CA for student in an organized health care education/training program
2,551
Unique beneficiaries
$121
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~384 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
1,433 | $42 | $114 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
984 | $53 | $135 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
978 | $45 | $147 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
548 | $42 | $111 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
481 | $149 | $303 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
462 | $106 | $225 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 260 | $416 | $2,082 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
226 | $169 | $492 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
163 | $64 | $163 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
156 | $12 | $36 |
| Nuclear stress test with CT scan A nuclear medicine imaging test that evaluates blood flow in the heart muscle at rest and during stress, performed alongside a concurrent CT scan. |
130 | $1,737 | $4,400 |
| PET scan of heart muscle blood flow A nuclear medicine imaging test that uses positron emission tomography (PET) to evaluate blood flow within the heart muscle. |
129 | $124 | $314 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
109 | $161 | $438 |
| New patient office visit, complex (60-74 min) | 75 | $170 | $429 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
73 | $22 | $70 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
73 | $99 | $216 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
66 | $79 | $400 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
46 | $180 | $569 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
34 | $390 | $1,057 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
30 | $143 | $419 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
28 | $66 | $123 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
23 | $22 | $150 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
23 | $720 | $1,183 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.0% high complexity
16.1% medium
78.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$18,265
Total received (2018-2024)
Avg $2,609/year across 7 years
Top 2% in CA for student in an organized health care education/training program
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
861
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,085 (99.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$180 (1.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,627
2023
$2,610
2022
$3,321
2021
$2,454
2020
$1,911
2019
$2,944
2018
$2,398
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$435
Boehringer Ingelheim Pharmaceuticals, Inc.
$338
AstraZeneca Pharmaceuticals LP
$299
PFIZER INC.
$232
Janssen Pharmaceuticals, Inc
$193
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$183
Medtronic, Inc.
$159
E.R. Squibb & Sons, L.L.C.
$106
Kiniksa Pharmaceuticals International, plc
$104
Amgen Inc.
$76
Merck Sharp & Dohme LLC
$71
SCPHARMACEUTICALS INC.
$59
SANOFI-AVENTIS U.S. LLC
$56
CARDIVA MEDICAL, INC.
$48
Abbott Laboratories
$43
Bayer Healthcare Pharmaceuticals Inc.
$41
Kestra Medical Technology Services, Inc.
$37
Boston Scientific Corporation
$32
Alnylam Pharmaceuticals Inc.
$28
ANI Pharmaceuticals, Inc.
$28
Davol Inc.
$23
CVRx, Inc.
$23
Esperion Therapeutics, Inc.
$13
Top 3 companies account for 40.8% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$2,567
Janssen Pharmaceuticals, Inc
$2,256
AstraZeneca Pharmaceuticals LP
$1,493
Amgen Inc.
$1,461
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,321
PFIZER INC.
$1,294
SANOFI-AVENTIS U.S. LLC
$927
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$649
E.R. Squibb & Sons, L.L.C.
$632
Merck Sharp & Dohme LLC
$493
Abbott Laboratories
$454
Gilead Sciences, Inc.
$338
Esperion Therapeutics, Inc.
$303
Medtronic, Inc.
$295
Amarin Pharma Inc.
$237
Regeneron Healthcare Solutions, Inc.
$233
Kiniksa Pharmaceuticals, Ltd.
$189
Astellas Pharma US Inc
$180
Actelion Pharmaceuticals US, Inc.
$180
W. L. Gore & Associates, Inc.
$175
Bayer HealthCare Pharmaceuticals Inc.
$163
Kestra Medical Technology Services, Inc.
$161
Alnylam Pharmaceuticals Inc.
$161
Merck Sharp & Dohme Corporation
$150
Boston Scientific Corporation
$143
CARDIVA MEDICAL, INC.
$137
ARBOR PHARMACEUTICALS, INC.
$132
HeartFlow, Inc.
$119
Medtronic Vascular, Inc.
$113
CVRx, Inc.
$105
Kiniksa Pharmaceuticals International, plc
$104
Arbor Pharmaceuticals, Inc.
$99
Allergan Inc.
$86
Lexicon Pharmaceuticals, Inc.
$67
Impulse Dynamics (USA) Inc.
$66
Kowa Pharmaceuticals America, Inc.
$60
Bayer Healthcare Pharmaceuticals Inc.
$59
SCPHARMACEUTICALS INC.
$59
ABIOMED
$54
Invuity, Inc.
$45
BIOTRONIK INC.
$40
Cardiovascular Systems Inc.
$37
iRhythm Technologies, Inc.
$37
Corindus Inc.
$36
Novo Nordisk Inc
$36
Philips Electronics North America Corporation
$35
Baxter Healthcare
$30
Amicus Therapeutics, Inc.
$29
Daiichi Sankyo Inc.
$28
ANI Pharmaceuticals, Inc.
$28
Bardy Diagnostics, Inc.
$26
GENZYME CORPORATION
$23
Davol Inc.
$23
PORTOLA PHARMACEUTICALS, INC.
$23
Biom'Up France SAS
$22
CardioFocus, Inc.
$20
Smith+Nephew, Inc.
$19
Chiesi USA, Inc.
$15
Top 3 companies account for 34.6% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · AMVUTTRA · ANDEXXA · ARISTA AH FlexiTip · Adempas · Arcalyst · Assure WCD · Azure · BEVYXXA · BRILINTA · BYSTOLIC · Barostim Neo System · CAMZYOS · CARDIOFORM Septal Occluder · CARDIOMEMS · CARDIVA VASCADE MVP VVCS 6-12F · CHANTIX · Cardiva VASCADE MVP VVCS 6-12F · Carnation Ambulatory Monitor · ClosureFast · Confirm Rx · CorPath GRX · Corlanor · Coronary Orbital Atherectomy System · ELIQUIS · ENTRESTO · EVKEEZA · Edarbi · FABRAZYME · FARXIGA · FFRct · FUROSCIX · GORE CARDIOFORM Septal Occluder · HeartLight System · HemoBlast Bellows · Hillrom - Cardiac Ambulatory Monitor · IGT Device Undivided · INJECTAFER · Impella · Inpefa · JARDIANCE · KENGREAL · Kerendia · LATITUDE · LEQVIO · Letairis · LifeVest · Livalo · MICRA · MITRACLIP · MULTAQ · NEXLETOL · ONPATTRO · OPSUMIT · OPSUMIT MACITENTAN · Optimizer · Otovel · Ozempic · PERCLOSE PROSTYLE · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PULSESELECT · PURIFIED CORTROPHIN GEL · Photonblade · RENASYS GO v2 HOME · REVEAL LINQ · Repatha · Reveal LINQ · UPTRAVI · VERQUVO · VYNDAQEL · Vascepa · Vascular Closure Device · VenaSeal · WAINUA · WATCHMAN Access System · WATCHMAN FLX · XARELTO · ZIO Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for student in an organized health care education/training program in CA.
Geographic Context
Student in an organized health care education/training programs within 10 mi
15,052
Per 100K population
152.8
County median income
$87,760
Nearest hospital
MEMORIALCARE LONG BEACH MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sklash is a remote & cardiac specialist, with above-average Medicare volume (top 3% in CA), with low-engagement industry engagement in the top 2% of CA peers, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sklash experienced with remote patient monitoring management, 20 min/month?
Based on Medicare claims data, Dr. Sklash performed 1,433 remote patient monitoring management, 20 min/month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sklash receive payments from pharmaceutical companies?
Yes. Dr. Sklash received a total of $18,265 from 58 companies across 861 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sklash's costs compare to other student in an organized health care education/training programs in Long Beach?
Dr. Sklash's average Medicare payment per service is $121. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sklash) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Student In An Organized Health Care Education/training Programs in Long Beach
Browse student in an organized health care education/training programs in Long Beach ranked by procedure volume and transparency data.
Highest volume
Top Student In An Organized Health Care Education/training Programs in CA
Student in an organized health care education/training programs ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Student In An Organized Health Care Education/training Programs in CA
Which CA student in an organized health care education/training programs receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology